Showing results (51-60 of 205) with videos related to

Sort By:
Pageof 21
Plos One|September 9, 2025
Evaluating antibody mediated opsonophagocytosis of bacteria via lab protocol: RAW 264.7 cell phagocytosis assayMatthew Slarve, Travis Nielsen, Dongran Yu, et al.
The Journal of Antimicrobial Chemotherapy|November 28, 2009
The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosisAshraf S Ibrahim, Teclegiorgis Gebremariam, Samuel W French, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 14, 2009
Recent advances in the management of mucormycosis: from bench to bedsideBrad Spellberg, Thomas J Walsh, Dimitrios P Kontoyiannis, et al.
Open Forum Infectious Diseases|November 18, 2020
Pharmacology, Dosing, and Side Effects of Rifabutin as a Possible Therapy for Antibiotic-Resistant Acinetobacter InfectionsMatthew C Phillips, Noah Wald-Dickler, Katherine Loomis, et al.
Antimicrobial Agents and Chemotherapy|October 22, 2008
Posaconazole mono- or combination therapy for treatment of murine zygomycosisAshraf S Ibrahim, Teclegiorgis Gebremariam, Julie A Schwartz, et al.
BMC Microbiology|November 4, 2015
Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studiesTravis B Nielsen, Kevin W Bruhn, Paul Pantapalangkoor, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2012
Macrophage killing of bacterial and fungal pathogens is not inhibited by intense intracellular accumulation of the lipoglycopeptide antibiotic oritavancinBeverlie Baquir, Sandrine Lemaire, Françoise Van Bambeke, et al.
JAMA Internal Medicine|April 1, 2020
Evaluation of a Paradigm Shift From Intravenous Antibiotics to Oral Step-Down Therapy for the Treatment of Infective Endocarditis: A Narrative ReviewBrad Spellberg, Henry F Chambers, Daniel M Musher, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumanniiJiaqi Cheng, Jun Yan, Zeferino Reyna, et al.
Clinical Microbiology Reviews|December 16, 2016
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of ChallengesDarren Wong, Travis B Nielsen, Robert A Bonomo, et al.
Pageof 21